Please Wait.....
Report
Peptide Therapeutics Market Report by Type (Innovative, Generic), Type of Manufacturer (Outsourced, In-House), Synthesis Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, Hybrid Technology), Routes of Administration (Parenteral, Oral, and Others), Application (Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, and Others), and Region 2023-2028
Market Report I 2023-11-24 I 149 Pages I IMARC Group
The global peptide therapeutics market size reached US$ 39.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9.10% during 2022-2028.
Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.
Peptide Therapeutics Market Trends:
The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.
Breakup by Type:
Innovative
Generic
Breakup by Type of Manufacturer:
Outsourced
In-house
Breakup by Synthesis Technology:
Solid Phase Peptide Synthesis
Liquid Phase Peptide Synthesis
Hybrid Technology
Breakup by Routes of Administration:
Parenteral
Oral
Others
Breakup by Application:
Gastrointestinal Disorders
Neurological Disorders
Metabolic Disorders
Cancer
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.
Key Questions Answered in This Report
1. How big is the global peptide therapeutics market?
2. What is the expected growth rate of the global peptide therapeutics market during 2023-2028?
3. What are the key factors driving the global peptide therapeutics market?
4. What has been the impact of COVID-19 on the global peptide therapeutics market?
5. What is the breakup of the global peptide therapeutics market based on the type?
6. What is the breakup of the global peptide therapeutics market based on the type of manufacturer?
7. What is the breakup of the global peptide therapeutics market based on the synthesis technology?
8. What is the breakup of the global peptide therapeutics market based on the routes of administration?
9. What is the breakup of the global peptide therapeutics market based on the application?
10. What are the key regions in the global peptide therapeutics market?
11. Who are the key players/companies in the global peptide therapeutics market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Peptide Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Innovative
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generic
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type of Manufacturer
7.1 Outsourced
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 In-house
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Synthesis Technology
8.1 Solid Phase Peptide Synthesis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Liquid Phase Peptide Synthesis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hybrid Technology
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Routes of Administration
9.1 Parenteral
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Application
10.1 Gastrointestinal Disorders
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Neurological Disorders
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Metabolic Disorders
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Cancer
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Amgen Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Apitope International NV
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Arch Biopartners Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 AstraZeneca plc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Circle Pharma Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Corden Pharma GmbH
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 F. Hoffmann-La Roche AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Ipsen Group
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Lonza Group AG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Novo Nordisk A/S
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Pfizer Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Teva Pharmaceuticals Industries Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Zealand Pharma A/S
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2022
Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2022
Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2022
Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2022
Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2022
Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis
Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2023-2028
Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2023-2028
Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2023-2028
Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Peptide Therapeutics Market: Competitive Structure
Table 9: Global: Peptide Therapeutics Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security